Buprenorphine Tablet
Product Images NDC 50090-5805

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 50090-5805). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine 01)

Chemical structure of buprenorphine hydrochloride, showing its molecular framework including aromatic rings, hydroxyl groups, methoxy groups, and a cyclopropylmethyl group attached to the nitrogen atom.*

FDA Label Image

Image (Buprenorphine 02)

An instructional line drawing shows a person placing a sublingual tablet under their tongue using fingers. The illustration emphasizes correct placement of the tablet for sublingual administration.*

FDA Label Image

Label Image (Lbl500905805)

Label for BUPRENORPHINE sublingual tablets, strength 8 mg, distributed by A-S Medication Solutions. The label specifies the package contains 30 sublingual tablets and includes storage instructions at 68 to 77 degrees Fahrenheit. Product NDC is 50090-5805.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.